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Abstract
UDP-galactopyranose mutase (UGM) is a flavoenzyme that catalyzes the conversion of UDP-galactopyranose to UDP-
galactofuranose, the precursor of galactofuranose (Galf ). Galf is found in several pathogenic organisms, including the
parasite Trypanosoma cruzi, the causative agent of Chagas’ disease. Galf is important for virulence and is not present in
humans, making its biosynthetic pathway an attractive target for the development of new drugs against T. cruzi. Although
UGMs catalyze a non-redox reaction, the flavin must be in the reduced state for activity and the exact role of the flavin in
this reaction is controversial. The kinetic and chemical mechanism of TcUGM was probed using steady state kinetics,
trapping of reaction intermediates, rapid reaction kinetics, and fluorescence anisotropy. It was shown for the first time that
NADPH is an effective redox partner of TcUGM. The substrate, UDP-galactopyranose, protects the enzyme from reacting
with molecular oxygen allowing TcUGM to turnover ,1000 times for every NADPH oxidized. Spectral changes consistent
with a flavin iminium ion, without the formation of a flavin semiquinone, were observed under rapid reaction conditions.
These data support the proposal of the flavin acting as a nucleophile. In support of this role, a flavin-galactose adduct was
isolated and characterized. A detailed kinetic and chemical mechanism for the unique non-redox reaction of UGM is
presented.
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Introduction
The protozoan parasite Trypanosoma cruzi is the etiological agent
of American trypanosomiasisorChagas’disease.TheWorld Health
Organization estimates that 8–11 million people are infected with
this disease in South and Central America [1]. Transmission occurs
when a triatomine insect feeds on a human subject and defecates at
the bite site [2]. Through rubbing, infected feces enter the bite
wound, mouth, eyes, or open cuts. Transmission by blood
transfusion, organ transplant, oral contamination, and congenital
routeshasalso been reported [3–7].T.cruzi has a dynamiclife cycle,
involving several morphological changes as the parasites travel from
the insect vector to humans [8]. This is accompanied by several
changes in cell surface sugar composition, which plays an important
role in infection and resistance to the host immune system [9,10].
Targeting the enzymes involved in biosynthesis of cell surface
glycans may lead to the identification of new inhibitors that function
as novel antiparasitic drugs for the treatment of Chagas’ disease
[11]. One unique sugar found on the cell surface of T. cruzi is
galactofuranose (Galf ) [11].
Galf, the five-membered ring form of galactose, is a component
of the cell wall, glycolipids, and glycoproteins on the cell surface of
many human pathogens including bacteria, fungi, and parasites
[11–14]. In T. cruzi, Galf is found in glycoprotein oligosaccharides
and glycoinositolphospholipids, which are involved in parasite
pathogenesis [11,15,16]. Additionally, Galf is not present in
humans. Thus, the biosynthetic pathway of Galf is an attractive
drug target for T. cruzi and other eukaryotic pathogens including
A. fumigatus and L. major [11,17]. UDP-galactopyranose mutase
(UGM) catalyzes the conversion of UDP-galactopyranose (UDP-
Galp) to UDP-galactofuranose (UDP-Galf ), the precursor of Galf
found on the cell surface (Figure 1) [18]. UGM is a unique
flavoprotein, as it requires the flavin to be reduced in order to
catalyze a non-redox reaction (Figure 2) [19,20]. The role of the
flavin cofactor in catalysis is controversial. Experimental and
structural data supports the role of the flavin acting as a
nucleophile [21,22]. Similarly, studies with flavin analogs and
potentiometry experiments suggest that a single electron transfer
step is necessary for catalysis [23,24]. Here, we present a complete
characterization of the recombinant form of UGM from T. cruzi
(TcUGM). We utilize steady state kinetics, fluorescence anisotro-
py, rapid reaction kinetics, and the trapping of reaction
intermediates to provide a clear view of the kinetic and chemical
mechanisms employed by this unique enzyme. We also identify
NAD(P)H as an effective electron donor to TcUGM, a function
that is unique to eukaryotic UGMs.
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Materials
UDP, UDP-galactopyranose, and BL21-T1
R chemical compe-
tent cells were purchased from Sigma (St. Louis, MO). Accuprime
polymerase and TOP-10 chemical competent cells were obtained
from Invitrogen (Carlsbad, CA). The restriction endonucleases SgfI
and PmeI were obtained from Promega (Madison, WI). Plasmid
miniprep and PCR purification kits were from Qiagen (Valencia,
CA). All other buffers and chemicals for biochemical studies were
purchased from Fisher Scientific (Pittsburgh, PA). Expression
plasmids, pVP55A and pVP56K, were obtained from the Center
for Eukaryotic Structural Genomics, University of Wisconsin,
Madison [25]. All reagents and solvents used in the synthesis of
UDP-Galf, if not specified otherwise, were obtained from Sigma-
Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) and
were used without further purification. All the synthetic reactions
were monitored to completion using thin layer chromatography
(TLC) with p-anisaldehyde staining for visualizing carbohydrates
along with UV detection when possible.
1H and
13C NMR were
recorded on a 400MR Varian-400 MHz spectrometer. CHCl3
(7.27 ppm) or HOD (4.79 ppm) were used as an internal
reference.
Cloning
T. cruzi UGM (TcUGM) was amplified by PCR from genomic
DNA using 59-GGTTGCGATCGCCATGGCAGAATTATT-
GACACC -39(SgfI site is underlined) as the forward primer and
59- CCAAGTTTAAACCATATCCTTCTGCAGTAGTC -39
(PmeI site is underlined) as the reverse primer. The TcUGM gene
was inserted into the pVP55A and pVP56K vectors as previously
described [17].
Protein expression and purification
Protein expression and purification of TcUGM was performed
following methods previously described for A. fumigatus UGM with
an additional final step of size exclusion chromatography in
25 mM HEPES, 125 mM NaCl, pH 7.5 (S-75, GE Healthcare,
Piscataway, NJ) [17]. Purified TcUGM was concentrated, flash
frozen in liquid N2, and stored at 280uC.
UV–visible absorbance spectrophotometry
The spectrum of recombinant TcUGM was recorded using an
Agilent 8453 UV–visible spectrophotometer. The extinction coeffi-
cient was determined by dividing the absorbance value at 450 nm of
the bound flavin in TcUGM by the absorbance value at 450 nm of
free flavin (obtained by heat denaturation and centrifugation of the
recombinant enzyme) and multiplying this value by the known
extinction coefficient for FAD (eFAD=11.3 mM
21cm
21) [26].
Solution molecular weight determination
The molecular weight of TcUGM was determined using size
exclusion chromatography as previously described [17,27].
NAD(P)H oxidation assays
Oxidation of NAD(P)H was monitored at 340 nm for 5 min.
Reactions were performed at room temperature with air saturated
50 mM sodium phosphate buffer, pH 7.0, with various concen-
trations of NAD(P)H, in the presence or absence of 0.5 mM UDP-
Galp. The reaction was initiated by addition of 1 mM enzyme.
Flavin reduction by NAD(P)H
Flavin reduction by NAD(P)H was performed anaerobically in a
glove box (Coy, Grass Lake, MI) using an Applied Photophysics
Stopped Flow SX20 (Leatherhead, UK). Reactions were per-
formed at 15uC. Buffer (50 mM sodium phosphate pH 7.0) was
made anaerobic by eight cycles of vacuum and argon flushing,
each for 45 minutes. After this procedure, protocatechuate
(400 mM) and protocatechuate dioxygenase (10 mg/mL) were
added to the buffer to function as an oxygen scavenging system.
All the solutions were prepared with the anaerobic buffer in the
glove box. NAD(P)H solutions were prepared by dissolving the
appropriate amounts in anaerobic buffer and concentrations were
Figure 1. Reaction catalyzed by TcUGM.
doi:10.1371/journal.pone.0032918.g001
Figure 2. The two proposed chemical mechanisms for UGMs. In one mechanism the reduced FAD (1) is depicted to act as a nucleophile
forming a flavin-galactose adduct (either via SN1o rS N2) (2) and a subsequent iminium ion (3). These steps are followed by ring contraction forming
the galactofuranose (4). An alternative mechanism predicts an electron transfer step, in which one electron is transferred from FADH
2 to an
oxocarbenium ion intermediate (6) creating a flavin and a sugar radical, which react and form the galactose-FAD adduct (2), followed by ring
contraction.
doi:10.1371/journal.pone.0032918.g002
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anaerobic by degassing with six 15 min cycles of vacuum and
flushing with anaerobic argon. To ensure complete anaerobiosis,
the solution was passed through a 2 mL desalting column
previously equilibrated with anaerobic buffer. Enzyme with a
final concentration of ,7.5 mM (after mixing) was mixed with
various concentrations of NAD(P)H and the reaction was
monitored with a photodiode array spectrophotometer until
complete reduction was achieved. Identical experiments were
performed in the presence of 0.5 mM UDP-Galp. Change in
absorbance at 452 nm was fitted to a single exponential equation
and the resulting kobs values were plotted as a function of NAD(P)H
concentration. These data was fit with equation 1 to obtain the
rate constant for reduction (kred) and the Kd value.
kobs~
kred  ½ S 
Kdz½S 
ð1Þ
Synthesis of UDP-Galf
Synthesis of a-D-Galactofuranosyl bis(triethylammonium) phos-
phate (Galf-1-phosphate) was performed over a series of three steps
with methods adapted from previously published protocols [28–34].
Details of the synthesis and NMR data are outlined in the
supplementary material (File S1). UDP-Galf was synthesized
following published method reported by Poulin and coworkers [35].
Activity assay
The activity of recombinant TcUGM was tested with UDP-Galf
as the substrate following procedures previously described [17].
Concentration of TcUGM was determined based on bound flavin.
TcUGM (100 nM) was reduced with either 20 mM dithionite,
500 mM NADPH, or 2.5 mM NADH for each activity assay.
Viscosity Effects
Viscosity effects were determined using the activity assay as
described above. Reactions were done in the presence of 0, 5, 10,
20, and 30% glycerol, 800 mM UDP-Galf, 20 mM dithionite, and
200 nM TcUGM. The relative viscosity (grel) of the reaction was
determined using a reference table for different percentages of
glycerol in solution [36].
Fluorescence anisotropy
Synthesis of UDP-rhodamine was performed as previously
described [37]. The optimal concentration of TcUGM (30 mM)
and UDP-rhodamine (30 nM) for the binding assays was
determined following procedures established in our laboratory
for a related UGM enzyme from Aspergillus fumigatus [37]. Binding
of UDP-Galp to TcUGM was monitored in the presence and
absence of 10 mM sodium dithionite by measuring the changes in
anisotropy [37]. The Kd values were obtained using the equation
2, where m1 and m2 are the minimum and maximum anisotropy,
respectively; m3 is the slope, and m4 is the Kd.
y~m1z
(m2{m1)xm3
m
m3
4 zxm3
ð2Þ
Trapping of the flavin-galactose adduct
The procedure was adapted from Gruber et al. and optimized
for trapping and isolation of the adduct in TcUGM [22].
Reactions were prepared using 1 mM TcUGM, 200 mM UDP-
Galp, 1 M sodium cyanoborohyride, and 100 mM sodium
dithionite in a final volume of 15 mL with 100 mM sodium
phosphate buffer at pH 7.0. Reactions were incubated for 45 min
at room temperature then terminated with addition of 6 M HCl
and neutralized with 1 M sodium phosphate buffer at pH 7.0. A
final concentration of 200 mM NaCl was added. The sample was
then centrifuged to precipitate denatured protein from the yellow
solution containing the free flavin. The adduct was isolated using
HPLC (Shimadzu) by injecting the yellow solution onto a reverse
phase C18 column (Phenomenex Luna C18 5 microns,
25064.6 mm) equilibrated with 5% B (A: Water, B: 100%
acetonitrile). The column was washed for 5 min with 5% B, then a
15 min linear gradient to 15% B, followed by 20 min linear
gradient to 75% B. The flavin species were eluted at ,20–
24 minutes and were characterized by high-resolution mass
spectrometry (Virginia Tech Mass Spectrometry incubator).
Reaction of reduced TcUGM with UDP-Galp, UDP, and
UDP-glucose
Rapid reaction kinetics were done using the methods described
for the TcUGM reduction studies. However, reduced TcUGM
was prepared by addition of 20 mM sodium dithionite. Excess
dithionite was removed using a 2 mL desalting column. Reduced
TcUGM (,15 mM final concentration) was mixed with buffer
alone for a final concentration of 0.15 mM UDP-Galf, 0.25 mM
UDP-Galp, 0.25 mM UDP, and 0.25 mM UDP-glucose (UDP-
Glc). Spectra were collected on a logarithmic time base from
1.3 ms to 2 s using a photodiode array. The rate of the
intermediate formation was calculated by fitting the change in
absorbance at 452 nm to a double exponential equation 3.
u~cza1e{(k1 t)za2e{(k2 t) ð3Þ
Results
Expression and Purification
Successful expression of soluble TcUGM was accomplished in
the pVP56K vector [17]. The protein was expressed as an N-
terminal fusion to maltose binding protein (MBP) with an 86-His
tag, which aids in purification. BL21-T1
R cells containing the
pVP56K-TcUGM plasmid were grown in auto-induction medium
for 8 h at 37uC followed by overnight incubation at 25uC [38].
Approximately 9 g of cell paste per liter of media was obtained
and 1 mg of purified TcUGM was isolated for each g of cell paste.
Recombinant TcUGM contained noncovalently bound flavin
cofactor, which had a typical flavin spectrum with peaks at
376 nm and 448 nm with a shoulder at 468 nm (Figure S1). The
extinction coefficient was determined to be 10.8 mM
21 cm
21 at
450 nm.
Determination of the oligomeric state
Size exclusion chromatography was used to calculate a
molecular weight of 67,800610,000 Da for the recombinant
TcUGM (Figure S2). This value is consistent with the molecular
weight predicted for a single polypeptide (54,700 Da).
Oxidase activity with NADPH and NADH
The activity of all UGMs requires the flavin to be in the reduced
state. Although the prokaryotic enzymes have been extensively
studied, the mechanism of reduction is yet to be determined
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in the primary sequence of TcUGM, we tested whether this
enzyme was capable of reacting with reduced dinucleotides. The
oxidation of either NADH or NADPH was monitored in the
presence and absence of UDP-Galp under aerobic conditions.
Under this conditions, no mutase activity is measured, instead
what is measured is the steady-state reduction of the flavin cofactor
in TcUGM, which is slowly oxidized by molecular oxygen
(Figure 3). In the absence of UDP-Galp, a slow oxidase activity,
kox, was observed for both coenzymes, while a 6-fold lower KM
value was measured for NADPH. In the presence of UDP-Galp,a
minor decrease in kox was measured (Table 1). In contrast, when
the same activity was measured with recombinant M. tuberculosis
UGM (MtUGM), there was no measurable NAD(P)H oxidation
(Table 1). E. coli UGM has also been shown to be unable to react
with NAD(P)H [20,39].
Flavin reduction monitored by rapid reaction kinetics
The decrease in absorbance at 450 nm under anaerobic
conditions was measured in a stopped flow spectrophotometer to
determine the rate constant of flavin reduction of TcUGM by the
reduced coenzyme (Figure 4). The observed rate constant of flavin
reduction, kred, with NADPH was seven-fold faster than with
NADH (Table 2, Figure 4). Furthermore, the Kd value for
NADPH was five-fold lower than for NADH. These results suggest
that NADPH is the preferred coenzyme. Reduction of TcUGM
with NADPH was also tested in the presence of saturating UDP-
Galp. Under this condition, the kred value did not change,
demonstrating reduction is unaffected by the presence of UDP-
Galp (0.5760.01 s
21 in the absence of UDP-Galp versus
0.5760.04 s
21 in the presence of UDP-Galp).
Mutase activity
The activity of TcUGM reduced with NADPH and NADH was
measured and compared to the values obtained with dithionite
reduced enzyme (Table 3, Figure 5). The reverse reaction was
monitored to allow significant accumulation of product, as
equilibrium favors UDP-Galp over UDP-Galf (93% to 7%).
Saturation kinetics was observed as a function of UDP-Galf
concentration. Data were fit to the Michaelis-Menten equation
and very similar kcat values were obtained independent of the
source of reducing equivalents (Table 3). The KM values were also
very similar when the enzyme was reduced with NADPH or
dithionite. In contrast, a higher KM value was measured with
NADH as the reductant, which we attributed to the slower rate of
reduction by NADH (Table 3).
Viscosity effects
To determine if product release is the rate-limiting step, the
effect of viscosity on kcat was measured. This was done by
determining the activity of TcUGM at different concentrations of
glycerol. If product release was the rate-limiting step, a decrease in
the kcat value would be observed as the viscosity of the medium
increased. A plot of the ratio of the kcat values in water, (kcat)0, and
at each concentration of viscogen, (kcat)g, should yield a straight
line with a positive slope. A slope of 1 is expected if product release
is the rate-liming step. With TcUGM, a slope of zero was
observed, indicating that product release is not the rate
determining step in the reaction (Figure 6).
Determination of the binding affinity of UDP-Galp to
TcUGM
To determine if UDP-Galp binds to oxidized or reduced
TcUGM, we synthesized UDP-rhodamine to measure binding of
the substrate. Fluorescence anisotropy changes induced by release
of the bound chromophore to TcUGM upon binding of the
substrate can be used to calculate the dissociation constant
(Figure 7A) [37].UDP-Galp was found to have very weak affinity
to oxidized TcUGM. We tested concentrations of substrate as high
as 100 mM and were unable to measure binding. However, when
TcUGM was reduced with dithionite, a Kd of 70640 mM was
determined demonstrating UDP-Galp only binds to the reduced
state of TcUGM (Figure 7B).
Isolation of flavin-galactose adduct
In the UGM reaction, a novel role for the flavin cofactor has
been proposed. It was suggested that the flavin could attack UDP-
Galp at the anomeric carbon, leading to cleavage of the C-O bond
(Figure 2, 2). In the bacterial enzymes a flavin-galactose adduct
was isolated and characterized, supporting this role for the flavin
cofactor [21,22]. Involvement of a flavin sugar adduct in the
reaction of eukaryotic UGMs was investigated. The adduct was
trapped by performing activity assays in the presence of sodium
Figure 3. Oxidase activity of TcUGM with NAD(P)H. A) Scheme
representing the oxidase activity of TcUGM measured in this assay. B)
Activity of TcUGM measured in the presence and absence of saturating
concentration of UDP-Galp (0.5 mM) under air saturating conditions at
room temperature (NADPH (N), NADH (m), NADPH+UDP-Galp (&), and
with NADH+UDP-Galp (.)).
doi:10.1371/journal.pone.0032918.g003
Table 1. Kinetic parameters of NAD(P)H oxidation reactions
a.
NADH NADPH
kox,s
21 KM, mMk ox,s
21 KM, mM
TcUGM 0.01560.002 90620 0.03060.002 1562
TcUGM+UDP-Galp
b 0.01060.002 50620 0.009960.001 1965
MtUGM 1.8610
26 -1 . 1 610
26 -
NAD(P)H alone 1.8610
27 -4 . 7 610
27 -
aAll reactions were done at room temperature with air saturated buffer (50 mM
phosphate buffer pH 7.0).
bIn the presence of 0.5 mM UDP-Galp.
doi:10.1371/journal.pone.0032918.t001
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turnover. The flavin was extracted and then isolated by HPLC
(Figure 8A). Two major peaks were observed, one corresponding
to native FAD, while the other had spectral peaks at 230 nm,
315 nm, and 378 nm (Figure 8B). This flavin spectrum is
consistent with previous published spectra for the N5-flavin
adduct however the peak at 378 nm is indicative of a C4a-
oxygen-flavin adduct [21,40]. This compound was characterized
by high resolution mass spectrometry (HRMS) and shown to have
a mass of 966.1946 Da (Figure 8C). This mass closely corresponds
to the expected mass of the FAD-galactose adduct of
950.2340 Da; the difference corresponds to the mass of a hydroxyl
group. We propose that the flavin was hydroxylated at the C4a
position during the trapping and isolation process, which agrees
with the observed spectrum.
Monitoring the reaction of reduced TcUGM with UDP-
Galp, UDP-Galf, UDP, and UDP-Glc
The results presented in the previous section and the previously
published data, establish that a flavin-galactose adduct is formed in
the reaction catalyzed by UGMs. However, the mechanism
leading to the formation of this intermediate can occur via the
formation of a flavin and sugar radical (Figure 2, 6-2)o rb ya
direct nucleophilic attack by the flavin (Figure 2, 1-2). Since a
flavin semiquinone has distinct spectroscopic characteristics, we
used rapid reaction kinetics to monitor the reaction at early time
points. In this experiment, anaerobically reduced TcUGM was
mixed with either buffer alone, UDP, UDP-glucose (UDP-Glc),
UDP-Galp, or UDP-Galf in the stopped-flow spectrophotometer
and complete spectra were collected between 350 nm and 700 nm
(Figure 9). When the enzyme was mixed with buffer alone or with
UDP, no major spectral changes were detected (Figure 9A, buffer
alone not shown). Difference spectra of TcUGM after mixing with
UDP-Glc showed a slight decrease in absorbance at ,415 nm,
which agrees with previous data with UDP-Glc binding to Klebsiella
pneumoniae UGM (KpUGM) (Figure S3) [21,41]. TcUGM mixed
with either UDP-Galp or UDP-Galf showed the same spectral
changes with a decrease at ,405 nm, an isosbestic point at
,425 nm (red shifted 10 nm with UDP-Galp), and a peak at
,460 nm (Figure 9B, C). Equilibrium binding of UDP-Galp to
KpUGM showed similar flavin spectral changes, however, it was
red shifted by ,50 nm [21]. The change in absorbance at the
higher wavelengths was attributed to the formation of the iminium
ion intermediate [21]. As the change at higher wavelengths does
not occur upon binding of the known ligand UDP-Glc, but only
Figure 4. Anaerobic reduction of TcUGM with NAD(P)H.
Reduction was monitored using the stopped flow spectrophotometer
at 15uC. The data was collected from 2 ms to 100 s on a logarithmic
timescale. A) Changes in the spectra of oxidized TcUGM after mixing
with 0.5 mM NADPH over 23 s. B) Traces of the flavin reduction at
various concentrations of NADPH. The data were fit to a single
exponential decay equation. C) The kobs values were plotted as a
function NADPH (N) and NADH (m) concentrations and fitted using the
equation 2.
doi:10.1371/journal.pone.0032918.g004
Table 2. TcUGM Reduction by NAD(P)H
a.
kred,s
21 Kd, mM kred/Kd, mM
21 s
21
NADPH 0.6060.006 9863 0.006160.0001
NADH 0.08560.0006 550610 0.0001560.000002
aReactions were measured under anaerobic conditions at 15uCi n5 0m M
phosphate buffer pH 7.0.
doi:10.1371/journal.pone.0032918.t002
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correspond to the formation of the iminium ion in TcUGM
(Figure 2, 3). A k1 value of 310640 s
21 and a k2 value of
7.960.7 s
21 were obtained from fitting the absorbance changes at
452 nm to a double exponential equation (Figure 9D). We
attributed the fast rate to the formation of the iminium ion. Since
the rate of k2 closely matches the value of kcat, we concluded that it
is associated with the rate limiting step, which could be either ring
closing or reattachment of UDP. More importantly, upon mixing
reduced TcUGM and substrate, a flavin semiquinone was not
observed, suggesting either the semiquinone does not form or that
the rate of decay is faster than the rate formation.
Discussion
UGM belongs to a growing group of flavoproteins where the
protein environment modulates the reactivity of the flavin to
perform novel non-redox chemistries [42,43]. There are two
proposed mechanisms for UGM. The proposed mechanisms differ
on the steps leading to the formation of the flavin galactose adduct.
In one mechanism, the flavin acts as a nucleophile and attacks the
anomeric carbon leading to the formation of the flavin-galactose
adduct intermediate, which can either occur via a direct attack on
UDP-Galp (SN2) or on a postulated oxocarbenium ion interme-
diate (SN1)(Figure 2, 1-2). In the other mechanism, elimination of
UDP leads to the formation of an oxocarbenium ion followed by a
single electron transfer from the reduced flavin (Figure 2, 6),
forming a flavin seminquinone and sugar radical. Radical
rearrangement of the N5 of the flavin and subsequent recombi-
nation leads to the formation of the flavin-galactose adduct
(Figure 2, 2). Once the adduct is formed, the galactose ring opens
leading to the formation of a sugar-flavin iminium ion (Figure 2, 3)
[21,22]. After recyclization, the final step in the reaction involves
an attack on the anomeric carbon by UDP, leading to the
formation of UDP-Galf (Figure 2, 4-5).
These mechanisms were developed and supported by data
obtained entirely from studies on prokaryotic UGMs and several
aspects of the mechanism are not completely understood. It was
shown by position isotope effects (PIX) that the glycosidic bond
between galactose and UDP was broken during catalysis [44].
Later studies demonstrated that the semiquinone of the flavin is
stabilized in the presence of UDP and UDP-Galp and that UGM
is inactive with 5-dezaflavin, supporting the single electron transfer
mechanism [23,24]. The formation of a flavin N5-C1 galactose
adduct was then demonstrated by trapping the immium ion with
NaCNBH3 [21,22]. This result supports a mechanism in which the
flavin acts as a nucleophile. Furthermore, the structure of bacterial
enzymes in complex with UDP-Galp, show proper binding
conformation for nucleophilic attack by the flavin cofactor
[22,45]. Also in support of the nucleophilic mechanism, it was
also shown that the flavin was present as in the anionic
hydroquinone form, a feature that is indicative of the N5 being
a good nucleophile [21,24].
Here, we expressed and purified the eukaryotic UGM from the
parasite T. cruzi. Recombinant TcUGM was found to function as a
monomer in solution, which differs from both the dimeric
prokaryotic UGMs, and the tetrameric fungal UGM (AfUGM)
[17,20]. However, it is similar to the parasitic UGM from L. major
(LmUGM), which is also a monomer [27]. This suggests that
Figure 5. TcUGM activity with UDP-Galf. TcUGM was reduced with
either 20 mM dithionite (&), 0.5 mM NADPH(N), or 2.5 mM NADH(m).
Reactions were performed with 200 nM TcUGM incubated with varying
concentrations of substrate for 1 min at 37uC. The data were fit to the
Michaelis-Menten equation. Summary of data is presented in Table 3.
doi:10.1371/journal.pone.0032918.g005
Table 3. Steady state kinetics of TcUGM
a.
Reductant kcat,s
21 KM, mMk cat/KM, mM
21 s
21
Dithionite 13.460.3 140610 0.09360.006
NADPH 11.560.4 200620 0.05660.005
NADH 8.460.9 6906150 0.01260.001
aReactions were incubated at 37uC for 1 min in 25 mM Hepes, 125 mM NaCl
pH 7.5, and terminated by heat denaturation at 95uC. Reactions were
performed using saturating amounts of reductant (20 mM dithionite, 0.5 mM
NADPH, and 2.5 mM NADH).
doi:10.1371/journal.pone.0032918.t003
Figure 6. Viscosity effect on kcat. The effect of viscosity was
determined by measuring the activity of TcUGM as a function of
increasing concentrations of glycerol. The data was fit to a linear
equation; the dashed line depicts the results of a diffusion controlled
reaction. This line has a slope of 1.
doi:10.1371/journal.pone.0032918.g006
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higher percent amino acid identity (60% with LmUGM,
compared to 40% with AfUGM and 15% with EcUGM and
MtUGM). TcUGM was found to be active only in the reduced
form. Chemically reduced TcUGM has similar kinetic parameters
with UDP-Galf as substrate as other UGMs [17,27,28,45,46].
Having stable and active TcUGM, a series of experiments were
performed to address several unanswered questions about the
chemical mechanism. We sought to determine the source of the
reducing equivalents required for catalysis. In vivo, a common source
of reducing equivalents for flavoenzymes is NAD(P)H. It was
determined that recombinant TcUGM could reduced by NADPH
orNADHintheabsenceofUDP-Galp,an dw asox id iz e dve rysl ow ly
by molecular oxygen. In the presence of substrate, the reaction with
oxygen was decreased. Thus, substrate binding protects the enzyme
from oxidation, which is essential for activity since TcUGM is active
only in the reduced form. There is no a canonical NADPH binding
domain in the primary sequence of TcUGM, thus the binding site of
NADPH remains to be identified. The reactivity of TcUGM with
NAD(P)H is unique since prokaryotic UGMs are unable to react
with reduced coenzymes. Perhaps the bacterial enzymes have
specific redox partners in the cell.
The rate of flavin reduction by NAD(P)H was directly
monitored in the stopped-flow spectrophotometer. It was shown
that the rate constant of flavin reduction and the affinity for
NADPH was higher than for NADH. These results showed a 40-
fold higher kred/Kd value for NADPH over NADH, suggesting that
NADPH is the preferred coenzyme.
The rate of flavin reduction was not affected by the presence of
UDP-Galp, indicating that binding of UDP-Galp is not a
prerequisite for reduction. Furthermore, UDP-Galp only binds to
the reduced form of TcUGM, indicating that UDP-Galp binds after
flavin reduction. The Kd value of UDP-Galp for the reduced UGM
was determined to be 70640 mM by fluorescence anisotropy. Thus,
the kinetic mechanism starts with binding of NADPH followed by
hydride transfer and UDP-Galp binding. Binding of UDP-Galp
protects the enzyme from reacting with molecular oxygen. It can be
estimated from the kcat value (,12 s
21) and the rate of oxidation,
(0.01 s
21), that for every NADPH oxidized the enzyme can turn
over ,1000 times.
When reduced TcUGM was mixed with UDP-Galp or UDP-
Galf using stopped-flow spectroscopy only a small decrease in
absorbance at 415 nm and an increase at 460 nm was observed.
These changes were not observed when the enzyme was mixed
Figure 7. Fluorescence anisotropy assay to measure the affinity of UDP-Galp to TcUGM. A) UDP-rhodamine chromophore used in the
fluorescence anisotropy experiments. B) Fluorescence polarization binding assay. The binding of UDP-Galp to chemically reduced TcUGM was
monitored by measuring the changes in anisotropy as it displaces UDP-rhodamine from the active site. The Kd values were obtained using equation 3.
doi:10.1371/journal.pone.0032918.g007
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Therefore, we assigned the spectral changes to the formation of
the iminium ion. Similar spectral changes have been reported with
bacteria UGM under equilibrium conditions, which are consistent
with our conclusion [21]. Interestingly, the flavin semiquinone was
not observed suggesting either it does not occur or it decays rapidly
preventing detection. By addition of sodium cyanoborohydride
into the reaction mixture, a flavin-sugar adduct was trapped and
was isolated and characterized by mass spectroscopy. This result
validates the assignment of the iminium ion intermediate observed
in the stopped-flow experiments. This adduct has also been
characterized in KpUGM as a flavin N5-C1 galactose interme-
diate by HRMS and
1H NMR [21,22]. From our rapid reaction
kinetics data, the changes in flavin absorbance best fit a double
exponential equation with a fast and slow rate. We assign the fast
rate to the formation of the iminium ion, which occurs at
Figure 8. Trapping of a covalent flavin intermediate. A) HPLC traces of the flavin sugar adduct from free FAD. The peak eluding at 22.5 min is
the adduct, while the second peak at 23.6 min is FAD. B) Spectrum of the C4a- hydroxyflavin-galactose adduct. C) High resolution mass spectrometry
results of the peak containing the flavin adduct. The inset shows the structure of the adduct with a hydroxyl group at the flavin C4a-position.
doi:10.1371/journal.pone.0032918.g008
Figure 9. Rapid reaction kinetics with reduced TcUGM mixed with substrate and substrate analogs. The initial spectrum (1.2 ms) is
shown as a solid line, the final spectrum (14 ms for UDP-Galf and 1.5 s for all other analogs) as a dashed line, and intermediate time points as gray
lines (spectra every 1.26 ms for UDP-Galf and every tenth spectrum collected of 400 points on logarithmic time scale over 2 s for all other analogs).
Reduced TcUGM mixed with 0.25 mM UDP (A), 0.25 mM UDP-Galp (B), 0.15 mM UDP-Galf (C), and formation of the iminium ion monitored at 455 nm
(D). The data was fit to equation 3.
doi:10.1371/journal.pone.0032918.g009
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21. While the slow rate occurred at 7.960.7 s
21, and as
it closely matches the kcat value (,12 s
21), we propose that this
corresponds to the rate-limiting step. One possibility is that the
rate constant that controls kcat corresponds to product release. To
determine if product release is the rate-limiting step in the
reaction, viscosity effects studies on kcat were performed. If product
release is the slow step that determines the kcat value, a linear
decrease in the kcat value should be observed as a function of
increasing concentrations of viscogen. Using glycerol as a viscogen,
no changes in the kcat value was observed, clearly indicating that
product release is not the rate-limiting step in the reaction of
TcUGM. Therefore, we conclude that the rate-limiting step must
be ring closing or UDP reattachment. Further studies are needed
to elucidate between the two.
Our results from the rapid reaction kinetic analysis show that a
flavin iminium ion is formed and suggest that a flavin semiquinone
does not play a role in catalysis. Furthermore, we were able to trap
and characterize a flavin-galactose adduct. These data strongly
supports the role of the flavin as a nucleophile. We proposed that the
formation of this adduct occurs via a direct attack of the flavin (SN2
mechanism)ratherthan formationofanoxocarbeniumion,followed
by flavin attack (SN1 mechanism). Our conclusion is supported by
data from Sun et al. where linear free energy relationship (LFER)
studies with prokaryotic UGM reconstituted with various FAD
analogs show changes in kcat values that correlate linearly with
changes in the nucleophilicity of the flavin N5 (r value of 22.4),
which is consistent with an SN2 mechanism [47]. Also, previous
studies with E. coli UGM, it was shown that UDP-[2-deoxy-2-
fluoro]Galf functions as a substrate with a kcat value 10
3 slower than
the reported kcat with UDP-Galf [28]. In contrast, in studies with
glycosyltransferases, where the formation of an oxocarbenium ion is
knowntooccur,ithasbeenshown that substrates withfluorineatthe
C2 position destabilize the formation of the oxocarbenium ion
preventing the reaction from occurring [48–51]. Therefore, if the
UGM reaction proceeded by an oxocarbenium ion, UDP-[2-deoxy-
2-fluoro]Galf should act as an inhibitor instead of as a slow substrate.
Together, the data presented here provides a detailed description
of the mechanism of the parasitic TcUGM, which is summarized in
Figure 10. We show that TcUGM first binds to NADPH (Figure 10,
b), and after hydride transfer (Figure 10, c), UDP-Galp binds
(Figure 10,d). We propose that an adduct forms by direct attack of
the flavin to the C1 position of galactose (Figure 10, e), without the
formation of a flavin semiquinone or oxocarbenium ion. Ring
opening leads to the rapid formation of an iminium ion (Figure 10,
f). Product release was determined not to be rate limiting, therefore,
ring closing or formation of the glycosidic bond between Galf and
UDP represent the rate determining step(s) in this reaction. Since
UDP is predicted to remain bound in the active site, we believed
that formation of the anomeric bond will be fast, therefore, the slow
step is most probably the isomerization step (Figure 10, f to g). The
mechanism of TcUGM clearly shows a unique mode of action for
the flavin cofactor, where it functions as a nucleophile and a scaffold
for holding the reaction intermediates. These results will aid in the
development of new drugs against human pathogens such as T.
cruzi, A. fumigatus, and L. major.
Supporting Information
File S1 Synthesis of UDP-Galf.
(DOC)
Figure S1 Flavin spectrum and SDS-PAGE of purified
TcUGM.
(TIF)
Figure S2 Size exclusion chromatography of TcUGM. The
standards aprotinin (1, 6.5 kDa), ribonuclease (2, 13 kDa), ovalbumin
(3, 43 kDa), conoalbumin (4, 75 kDa), aldolase (5, 158 kDa), and
ferritin (6, 440 kDa) were used to calculate the Kav values using the
equation, Kav~ Ve{Vo
Vt|Vo

,w h e r eV ois the void volume of the column;
Vtisthe totalvolume ofthe columnand Veisthe elution volumeof the
protein). TcUGM is shown on the plot as a black square.
(TIF)
Figure 10. Chemical mechanism of TcUGM. The reaction requires the oxidized flavin cofactor (a) to be reduced for activity. First, NADPH binds
to the oxidized enzyme (b), and only after the flavin is reduced (c) will UDP-Galp bind (d). The flavin then acts as a nucleophile attacking the C1 of
galactose and forming a flavin sugar adduct (e), which occurs rapidly (f). This is followed by ring opening and recyclization (g). The rate limiting step
in the reaction corresponds to either galactose isomerization or reattachment of the UDP (f to g). We postulate that the rate limiting step is the
isomerization step. The final step is release of UDP-Galf, which occurs rapidly. The enzyme can proceed to the next reaction cycle or be slowly
oxidized by molecular oxygen (h to a).
doi:10.1371/journal.pone.0032918.g010
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with 0.25 mM UDP-Glc. Inset show the difference spectra.
(TIF)
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